KLP
NPCE icon

Kent Lake PR’s Neuropace NPCE Stock Holding History

Kent Lake PR’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$10.3M Buy
1,000,000
+75,000
+8% +$707K 5.21% 3
2025
Q2 		$10.3M Sell
925,000
-25,000
-3% -$313K 4.54% 6
2025
Q1 		$11.7M Sell
950,000
-532,555
-36% -$6.67M 5.39% 6
2024
Q4 		$16.6M Buy
1,482,555
+232,555
+19% +$2.02M 7.02% 1
2024
Q3 		$8.71M Buy
+1,250,000
New +$9.14M 3.46% 9

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Kent Lake PR's NPCE Position: Q3 2025 in Review

Kent Lake PR increased its Neuropace (NPCE) stake by 8.1% in Q3 2025, buying an estimated $707K and bringing the position to 1,000,000 shares worth $10.3M. The position accounts for 5.21% of the portfolio, ranked #3.

Kent Lake PR first reported a position in NPCE in Q3 2024 and has held it in 5 quarters since. The position peaked at $16.6M in Q4 2024. 80 funds tracked by Wall St. Rank hold NPCE as of Q3 2025.

  • Kent Lake PR held 1,000,000 shares of Neuropace worth $10.3M as of Q3 2025.
  • Kent Lake PR bought 75,000 Neuropace shares in Q3 2025, an estimated $707K.
  • Neuropace made up 5.21% of Kent Lake PR's portfolio in Q3 2025, its #3 holding.
  • Kent Lake PR first reported a position in Neuropace in Q3 2024 and has held it in 5 quarters since.
  • Kent Lake PR's Neuropace position peaked at $16.6M in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Neuropace as of Q3 2025.

Based on Kent Lake PR's 13F filing for Q3 2025, filed 14 Nov 2025.